Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

17.00p
   
  • Change Today:
      3.75p
  • 52 Week High: 45.20
  • 52 Week Low: 10.50
  • Currency: UK Pounds
  • Shares Issued: 133.49m
  • Volume: 1,784,664
  • Market Cap: £22.69m
  • RiskGrade: 594

Other News

FTSE in-depth: New M&S online boss welco... 09-Feb-2011 This Is Money
Yesterday's trading: Chinese whisper fuels Gulfs... 14-Sep-2009 This Is Money
Stock market report: Monday close 22-Dec-2008 This Is Money
Market report: Tuesday close 02-Oct-2007 This Is Money
Smaller companies report: Thursday close 26-Jan-2006 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 17.00p
Change Today 3.75p
% Change 28.30 %
52 Week High 45.20
52 Week Low 10.50
Volume 1,784,664
Shares Issued 133.49m
Market Cap £22.69m
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.5% below the market average46.5% below the market average46.5% below the market average46.5% below the market average46.5% below the market average
4.17% above the sector average4.17% above the sector average4.17% above the sector average4.17% above the sector average4.17% above the sector average
Price Trend
43.14% below the market average43.14% below the market average43.14% below the market average43.14% below the market average43.14% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 04-Apr-2025

Time Volume / Share Price
13:56 14,547 @ 16.00p
13:56 10,000 @ 16.20p
13:55 10,000 @ 16.20p
13:36 3,500 @ 17.40p
13:34 6,437 @ 16.64p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page